| 注册
首页|期刊导航|中国药理学通报|HIV-1整合酶3′端加工抑制剂筛选方法的建立与优化

HIV-1整合酶3′端加工抑制剂筛选方法的建立与优化

陆翠林 张旋 詹金彪 杨柳萌 郑永唐

中国药理学通报Issue(10):1469-1473,5.
中国药理学通报Issue(10):1469-1473,5.DOI:10.3969/j.issn.1001-1978.2014.10.029

HIV-1整合酶3′端加工抑制剂筛选方法的建立与优化

Establishment and optimization of a method for screening HIV-1 integrase 3′-processing inhibitor

陆翠林 1张旋 2詹金彪 1杨柳萌 2郑永唐3

作者信息

  • 1. 中国科学院昆明动物研究所,中国科学院和云南省动物模型与人类疾病机理重点实验室,云南 昆明 650223
  • 2. 中国科学院大学,北京 100039
  • 3. 浙江大学医学院生物化学系,浙江 杭州 310058
  • 折叠

摘要

Abstract

Aim To establish and optimize a method for screening HIV-1 integrase 3′-processing inhibitor. Methods Fluorescence resonance energy transfer ( FRET) was used to create an assay for screening in-tegrase 3′-processing inhibitors; wavelength was de-fined by DNaseⅠ; factors affecting IN activity were optimized, including buffer composition, substrate con-centration, enzyme concentration, metal ion concentra-tion. Results Integrase 3′-processing optimizing reac-tion conditions were buffer 1 , 500 nmol · L-1 sub-strate, 1 μmol·L-1 integrase, 20mmol·L-1 magne-sium ion. Positive drug raltegravir and myricetin could effectively inhibit integrase 3′-processing activity using this assay. Two integrase 3′-processing inhibitors were screened by this method. Conclusion The method for screening HIV-1 integrase 3′-processing inhibitor is successfully established and optimized.

关键词

HIV-1/整合酶/3′端加工/荧光共振能量转移/影响因素/优化/抑制剂

Key words

HIV-1/integrase/3′-processing/FRET/influence factors/optimization/inhibitor

分类

医药卫生

引用本文复制引用

陆翠林,张旋,詹金彪,杨柳萌,郑永唐..HIV-1整合酶3′端加工抑制剂筛选方法的建立与优化[J].中国药理学通报,2014,(10):1469-1473,5.

基金项目

国家自然科学基金资助项目( No 81102483) ( No 81102483)

国家科技部“重大新药创制”重大专项课题( No 2009ZX09501-029,2012ZX10001-006,2013ZX09103001-010) ( No 2009ZX09501-029,2012ZX10001-006,2013ZX09103001-010)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文